IPAD-DB ID | D00029 |
Name | Tamoxifen |
Category | Drugs |
2D Structure |
|
3D Structure | |
Molecular Formula | C 2 6 H 2 9 N O |
Molecular Weight | 371.5 g/mol |
IUPAC Name | 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine |
InChI | InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25- |
InChIKey | NKANXQFJJICGDU-QPLCGJKRSA-N |
Canonical SMILES | CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3 |
PubChem CID | 2733526 |
DrugBank Accession Number | DB00675 |
CAS Registry Number | 10540-29-1 |
Molecular Weight(Computed by SwissADME) | 371.51 |
Hac(Computed by SwissADME) | 28 |
Volume(Computed by ADMETlab 2.0) | 426.005 |
Density(Computed by ADMETlab 2.0) | 0.871 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 3 |
nHet(Computed by ADMETlab 2.0) | 2 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 19 |
Flexibility(Computed by ADMETlab 2.0) | 0.421 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -5.966 |
LogD(Computed by ADMETlab 2.0) | 4.781 |
logP(Computed by ADMETlab 2.0) | 5.745 |
TPSA(Computed by SwissADME) | 12.47 |
Hbond Acceptor(Computed by SwissADME) | 2 |
Hbond Donor(Computed by SwissADME) | 0 |
Rotatable Bonds(Computed by SwissADME) | 8 |
GI Absorption(Computed by SwissADME) | Low |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | Yes |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | Yes |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -3.5 |
Lipinski(Computed by SwissADME) | 1 |
Ghose(Computed by SwissADME) | 1 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 1 |
Muegge(Computed by SwissADME) | 1 |
Bioavailability Score(Computed by SwissADME) | 0.55 |